Sun Pharmaceutical

Pharmaceutical | January 05, 2017

Rajat Bose of rajatkbose.com told CNBC-TV18, "One should hold Sun Pharmaceutical Industries with a stoploss below Rs 550 and if it falls below Rs 600 then I would advocate further buying. For fresh buy one would buy at lower levels and put a strict stoploss below Rs 550. My sense is that its downtrend has been arrested but there is not quite a reversal yet. However, this would be the best time for a long term investor to buy more. So, I would suggest buy below Rs 600 if one is willing then bu...

Sun Pharmaceutical | April 13, 2017

Vijay Chopra of enochventures.com told CNBC-TV18, "I would recommend the investor to get out of power generation companies and get into a power trading company....

Sun Pharmaceutical Industries | April 24, 2017

Sun Pharmaceutical Industries (₹639.6) is ruling at a crucial level. The stock finds support at ₹610 and the crucial one at ₹572. A close below the latter will confirm the bearish trend....

Sun Pharmaceutical Industries Ltd | May 26, 2017

Sun Pharmaceutical Industries Ltd., India’s largest drugmaker, faces mounting pressure to resolve regulatory issues at one of its biggest factories to help offset sharply deteriorating generic drug prices in the U.S....